DOI: 10.1177/03000605261459935 ISSN: 0300-0605

Integration of single-cell cis-expression quantitative trait locus and Mendelian randomization analyses identifies a Treg-specific gene for precision therapy in rheumatoid arthritis, gonarthrosis, and gouty arthritis

Tianqi Ren, Yiwei Shen, Ji Li, Zhe Zhang, Zelin Liu, Lei Bao, Xue Li
Show PDF Cite

Objective

Arthritis, including rheumatoid arthritis, gonarthrosis, and gouty arthritis, poses a substantial public health challenge. Regulatory T cells are critical for immune homeostasis, and their dysfunction contributes to arthritis pathogenesis; however, the specific gene regulatory programs causally influencing disease susceptibility remain elusive. We aimed to identify regulatory T cell–specific therapeutic targets using single-cell cis-expression quantitative trait locus and Mendelian randomization.

Methods

We integrated single-cell regulatory T cell cis-expression quantitative trait locus data with genome-wide association study results from FinnGen R12 (16,314 rheumatoid arthritis, 61,356 gonarthrosis, and 12,342 gouty arthritis cases). Two-sample Mendelian randomization was employed to infer causality, using the inverse-variance weighted method, with rigorous sensitivity analyses conducted to ensure robustness.

Results

The analysis revealed distinct causal associations. In rheumatoid arthritis, upregulation of DexD/H-box helicase 60 like ( DDX60L) significantly increased the disease risk (odds ratio = 2.10), whereas OAS1 expression served as a protective factor (odds ratio = 0.65). For gonarthrosis, OAS1 again demonstrated a protective effect (odds ratio = 0.897), whereas janus kinase and microtubule interacting protein 2 ( JAKMIP2) was identified as a modest risk factor (odds ratio = 1.019). Conversely, no significant regulatory T cell–specific causal signals were observed for gouty arthritis.

Conclusions

OAS1 is a cross-disease regulatory T cell protector, whereas DDX60L and JAKMIP2 are disease-specific risk amplifiers. Engineering high-OAS1/low-DDX60L/low-JAKMIP2 regulatory T cells offers a genetically grounded blueprint for rheumatoid arthritis and gonarthrosis but not for gouty arthritis.

More from our Archive